Skip to Main Content

Paper Details

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.
Clin Cancer Res
11
2022
Author NameAffiliation
Naoto T UenoThe University of Texas MD Anderson Cancer Center
Gabriel N HortobagyiThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2